Takeda Pharmaceutical Company Limited Logo
2016-01-07 03:30
Takeda Acquires U.S. Biologics Manufacturing Facility
OSAKA, JAPAN--(Business Wire/Korea Newswire) January 7, 2016 -- Takeda Pharmaceutical Company Limited (TOKYO:4502) (http://goo.gl/eX9kbP) (“Takeda”) today announced the acquisition of a biologics manufacturing facility located in Brooklyn Park, Minnesota, U.S., from Baxalta US Inc (NYSE:BXLT). Takeda intends to use the facility primarily for the manufacture of Entyvio® (vedolizumab) and other biologic products, allowing the company to maximize global efficiencies and further enhance the product’s supply chain flexibility.

“Takeda’s focus is providing patients access to quality therapies,” said Thomas Wozniewski, Global Manufacturing and Supply Officer at Takeda. “Acquiring the state of the art Brooklyn Park facility and gaining access to a highly experienced and dedicated team is a very important strategic benefit for Takeda that reinforces and expands upon our global operations for Entyvio and future biologic products.”

The acquisition will also provide long-term strategic benefits for Takeda through enhanced capacities for the manufacture of additional commercial products and investigational drugs under clinical development. The plant allows Takeda to establish and develop direct commercial bio-manufacturing expertise. Terms of the transaction were not disclosed.

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda (TOKYO:4502) (http://goo.gl/eX9kbP) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160105005639/en/
Takeda Pharmaceutical Company Limited 전체 보도자료 보기
이 뉴스는 기업·기관이 발표한 보도자료 전문입니다. 언론 매체와 블로그는 보도를 목적으로 이 보도자료를 사용할 수 있습니다. 보도자료 등록 안내
Media Contact

Media Contacts:
Japanese Media
Tsuyoshi Tada
+81 (0)3-3278-2417

Media outside Japan
Jocelyn Gerst
+1 (224) 554-5542

이 보도자료 관련 분야

건강  제약  인수/합병  해외

관심 분야 보도자료 구독 방법

가입하면 관심 분야 보도자료를 마이 뉴스와 이메일로 볼 수 있습니다. 스마트폰과 RSS로도 가능합니다.

보도자료 배포 서비스 안내

뉴스와이어는 4천여개 언론매체에서 일하는 1만7천여명의 기자에 보도자료를 배포해 언론이 보도할 수 있게 합니다.

해외 보도자료 배포 안내
비즈니스와이어와 제휴해 해외 언론에 보도자료를 배포합니다.
국내 언론과 포털에 보도자료를 배포해 드립니다.
보도자료 통신사 뉴스와이어는 기업의 보도자료를 1백여 개 언론과 포털, 증권사 그리고 2만 명이 넘는 언론인, 전문가, 기업 회원에게 광범위하게 배포해 드립니다.
3천여 개 해외 언론에 보도자료를 전송합니다.
AP, Yahoo, New York Times, Google News, Dow Jones, The Wall Street Journal, Bloomberg, MSN, MSNBC, Factiva 등 3천여 개 매체에 보도자료를 배포해 드립니다.